{{위키데이터 속성 추적}}
{{구별|GM-CSF|에포에틴 알파}}
{{drugbox
| drug_name         = 
| INN               = 
| image = filgrastim.jpg
| width = 184
| alt               = 
| caption           = 
| type              = 
<!-- Clinical data -->
| pronounce         = 
| tradename = Neupogen, Zarxio, Granix, Grasin 등
| Drugs.com = {{drugs.com|monograph|filgrastim}}
| MedlinePlus       = a692033
| licence_CA        = <!-- Health Canada may use generic or brand name (generic name preferred) -->
| licence_EU        = yes
| DailyMedID        = Filgrastim
| licence_US        = Filgrastim
| pregnancy_AU      = B3
| pregnancy_AU_comment =<ref name="Drugs.com Pregnancy">{{웹 인용| title=Filgrastim Use During Pregnancy | website=Drugs.com | date=13 September 2018 | url=https://www.drugs.com/pregnancy/filgrastim.html | access-date=17 December 2019}}</ref>
| pregnancy_US      = N
| pregnancy_US_comment =<ref name="Drugs.com Pregnancy" />
| pregnancy_category = 
| dependency_liability = 
| addiction_liability = 
| routes_of_administration = IV, subQ
| class             = [[조혈제]]
| ATCvet            = 
| ATC_prefix = L03
| ATC_suffix = AA02
| ATC_supplemental  = 
<!-- Legal status -->
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_AU_comment = 
| legal_BR =  <!-- OTC, A1, A2, A3, B1, B2, C1, C2, C3, C4, C5, D1, D2, E, F-->
| legal_BR_comment = 
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_CA_comment = 
| legal_DE = <!-- Anlage I, II, III or Unscheduled-->
| legal_DE_comment = 
| legal_NZ = <!-- Class A, B, C -->
| legal_NZ_comment = 
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM / Class A, B, C -->
| legal_UK_comment = 
| legal_US = Rx-only
| legal_US_comment = 
| legal_UN = <!-- N I, II, III, IV / P I, II, III, IV-->
| legal_UN_comment = 
| legal_status      = <!--For countries not listed above-->
<!-- Pharmacokinetic data -->
| bioavailability   = 
| protein_bound     = 
| metabolism        = 
| metabolites       = 
| onset             = 
| elimination_half-life = 
| duration_of_action = 
| excretion         = 
<!-- Identifiers -->
| CAS_number = 121181-53-1
| CAS_supplemental  = 
| PubChem = 
| PubChemSubstance  = 46505833
| IUPHAR_ligand = 6968
| DrugBank = DB00099
| ChemSpiderID      = none
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = PVI5M0M1GW
| KEGG              = D03235
| ChEBI             = 
| ChEMBL = 1201567
| NIAID_ChemDB      = 
| PDB_ligand        = 
| synonyms          = filgrastim-aafi, filgrastim-sndz
<!-- Chemical and physical data -->
| IUPAC_name = [[인간]] [[과립세포군 촉진인자]]<br/>Human granulocyte colony stimulating factor (G-CSF)
| chemical_formula  = 
| C=845 | H=1343 | N=223 | O=243 | S=9
| SMILES            = 
| Jmol              = 
| StdInChI          = 
| StdInChI_comment  = 
| StdInChIKey       = 
| density           = 
| density_notes     = 
| melting_point     = 
| melting_high      = 
| melting_notes     = 
| boiling_point     = 
| boiling_notes     = 
| solubility        = 
| sol_units         = 
| specific_rotation = 
}}

'''필그라스팀''' (Filgrastim)은 [[조혈제]]로 분류되는 [[과립세포군 촉진인자|G-CSF]]의 한 종류로, [[호중구감소증]]의 치료에 사용한다.<ref name=AHFS2016>{{웹 인용|title=Filgrastim|url=https://www.drugs.com/monograph/filgrastim.html |publisher=The American Society of Health-System Pharmacists|access-date=8 December 2016|url-status=live|archive-url=https://web.archive.org/web/20170510112413/https://www.drugs.com/monograph/filgrastim.html |archive-date=10 May 2017}}</ref> [[부작용]]으로 [[발열]], [[기침]], [[흉통]], [[관절통]], [[구토]], [[탈모]] 등이 발생할 수 있고, [[알레르기 반응]]이나 [[비장파열]] 등이 발생할 수 있다.<ref name=AHFS2016/> [[경정맥]] 또는 [[경피]]로 투여한다.<ref name=AHFS2016/>

== 같이 보기 ==
* [[G-CSF]]
* [[GM-CSF]]
* [[조혈]]
* [[면역계]]
* [[염증]]
* [[리페그필그라스팀]]
* [[페그필그라스팀]]

== 각주 ==
{{각주}}

== 참고 문헌 ==
* {{서적 인용|editor-first1=Budiono | editor-last1=Santoso |editor-first2=Christoffel Jos |editor-last2=van Boxtel |editor-first3=Ralph I. | editor-last3=Edwards |title=Drug benefits and risks: international textbook of clinical pharmacology |publisher=Wiley |location=New York |year=2001 |pages= |isbn=0-471-89927-5 |oclc= |doi= | name-list-format =vanc}}

== 외부 링크 ==
* {{웹 인용| url = https://druginfo.nlm.nih.gov/drugportal/name/filgrastim | publisher = U.S. National Library of Medicine| work = Drug Information Portal| title = Filgrastim }}
* {{웹 인용| url = https://www.bioin.or.kr/board.do?cmd=view&bid=tech&num=260134 | publisher = (재)범부처신약개발사업단 | title = 호중구감소증 치료제 개발 현황 }}

{{전거 통제}}
{{토막글|의학}}

[[분류:화이자의 제품]]
[[분류:혈액 및 조혈기관에 작용하는 약]]
[[분류:면역 자극제]]
[[분류:재조합 단백질]]
[[분류:세계 보건 기구 필수 의약품]]
[[분류:애브비의 제품]]
[[분류:노바티스의 제품]]
[[분류:성장 인자]]